Clinical Trial

OMEGA-3-FATTY ACIDS IN CHILDREN WITH SICKLE CELL DISEASE

Name: OMEGA-3-FATTY ACIDS IN CHILDREN WITH SICKLE CELL DISEASE — clinical trial record (NCT07530965)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this feasibility study is to investigate the role of a dietary supplement in modulating the gut microbiota and improving pain outcomes in children with sickle cell disease (SCD).

Trial Details

NCT Number	NCT07530965
Lead Sponsor	University of Alabama at Birmingham
Conditions	Sickle Cell Disease (SCD)
Enrollment	20 participants
Start Date	2026-06-01
Primary Completion	2027-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-15